Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Gambia
Gambia: Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage was 80.0% in 2024. ▼ Falling
Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Gambia, 2010–2024
Source: WHO & UNICEF (2025); UN, World Population Prospects (2024) – processed by Our World in Data. Measured in %.
Analysis
In 2024, pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Gambia stood at 80.0%.
The figure is down 16.7% over ten years.
Over the whole period, pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Gambia peaked at 99.0% in 2010 and was at its lowest, 75.0%, in 2022.
That places Gambia 104th out of 146 countries with data for 2024, putting it in the middle of the range.
The long-run direction has been consistently falling across the 15 years of available data.
Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Gambia, year by year
| Year | % | Change |
|---|---|---|
| 2010 | 99.0% | — |
| 2011 | 95.0% | -4.0% |
| 2012 | 98.0% | +3.2% |
| 2013 | 96.0% | -2.0% |
| 2014 | 96.0% | +0.0% |
| 2015 | 97.0% | +1.0% |
| 2016 | 95.0% | -2.1% |
| 2017 | 90.0% | -5.3% |
| 2018 | 93.0% | +3.3% |
| 2019 | 87.0% | -6.5% |
| 2020 | 83.0% | -4.6% |
| 2021 | 78.0% | -6.0% |
| 2022 | 75.0% | -3.8% |
| 2023 | 80.0% | +6.7% |
| 2024 | 80.0% | +0.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 94.6% | 87.0% | 99.0% | 10 |
| 2020s | 79.2% | 75.0% | 83.0% | 5 |
Countries ranked near Gambia
More health data for Gambia
- Un projection of annual infant deaths, annual growth rate -1.27 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 1.15 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,044 deaths per 1,000 people (2090)
- Number of infants who die before age 1 700 deaths (2100)
- Population ages 75-79, female, annual growth rate 1.6 % change on previous year (2025)
- Population ages 75-79, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 75-79, female, per capita 0.0027 units per person (2025)
- Population ages 75-79, male, annual growth rate -0.162 % change on previous year (2025)
- Population ages 75-79, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 75-79, male, per capita 0.0022 units per person (2025)
Frequently asked questions
- What is pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Gambia?
- Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Gambia was 80.0% in 2024, according to WHO & UNICEF (2025); UN, World Population Prospects (2024) – processed by Our World in Data.
- What is the highest pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage recorded in Gambia?
- The highest recorded value was 99.0% in 2010.
- What is the lowest pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage recorded in Gambia?
- The lowest recorded value was 75.0% in 2022.
- How does Gambia rank for pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage?
- Gambia ranks 104th out of 146 countries with data for 2024.
- Is pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage rising or falling in Gambia?
- Over the last ten years it is down 16.7%. The long-run trend across the full record is falling.
- Where does this Gambia data come from?
- The figures come from WHO & UNICEF (2025); UN, World Population Prospects (2024) – processed by Our World in Data, published as part of Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 15 observations, free to reuse under CC BY 4.0 (Our World in Data).
About this data
Share of one-year-olds who have had the third dose of the pneumococcal conjugate vaccine in a given year.